Clinical trial / 2016
Probiotic milk supplementation for 12 weeks improved cognitive function and several metabolic markers in patients with Alzheimer's disease.
Sixty patients with Alzheimer's disease were randomized to receive 200 ml/day of control milk or probiotic milk containing Lactobacillus acidophilus, L. casei, Bifidobacterium bifidum, and L. fermentum for 12 weeks. Compared to controls (-5.03% ± 3.00), the probiotic group showed a significant improvement in MMSE scores (+27.90% ± 8.07, P < 0.001). Probiotic intake also led to significant favorable changes in plasma malondialdehyde, serum hs-CRP, HOMA-IR, beta cell function, serum triglycerides, and QUICKI compared with control (all P < 0.01). No considerable effects were observed on fasting plasma glucose, other lipid profiles, or other biomarkers of oxidative stress and inflammation.
- Study type
- Randomized, double-blind, controlled clinical trial
- Who was studied
- 60 patients with Alzheimer's disease
- What was measured
- MMSE score, oxidative stress, inflammation, and metabolic markers
THE PAPER
Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial.
Akbari E, Asemi Z, Daneshvar Kakhaki R, Bahmani F, Kouchaki E, Tamtaji OR, Hamidi GA, Salami M. Front Aging Neurosci, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.